ASTERDM

Q4FY26 Quarterly Result Announced for Aster DM Healthcare Ltd.

Q4FY26 Quarterly Result Announced for Aster DM Healthcare Ltd.

Healthcare Facilities company Aster DM Healthcare announced Q4FY26 results Revenue for Q4FY26 grew 18% YoY to Rs 1,182 crore. Operating EBITDA (ex-Kasaragod) grew 31% YoY to Rs 253 crore in Q4FY26. Operating EBITDA Margins (ex-Kasaragod) stood at 21.7% in Q4FY26 vs. 19.3% in Q4FY25. Normalised PAT1 (ex-Kasaragod) grew 45% YoY to Rs 153 crore In Q4FY26. Azad Moopen, Founder & Chairman, Aster DM Healthcare, said: “We are very pleased that the merger of Aster DM Healthcare and Quality Care India Limited (QCIL), in partnership with Blackstone, is progressing towards completion in Q1FY27. The overwhelming shareholder support, with 96.68% votes in favour, reflects strong confidence in our vision of building a scaled and integrated healthcare platform. On a proforma basis, Q4FY26 revenues grew 18% YoY to Rs 2,361 crore, while operating EBITDA increased 25% YoY to Rs 517 crore, supported by strong growth in patient volumes, and continued margin expansion. The combined entity will have a capacity of over 10,623 beds across 28 cities, with an additional pipeline of around 4,445 beds, providing clear visibility to exceed 15,500 beds in the near term, thus . This positions the platform to become one of the top three healthcare providers in India.” “Our performance this quarter reflects consistent execution, with revenues growing 18% YoY to Rs 1,182 crore. Excluding the impact of the newly commissioned Kasargod facility, operating EBITDA grew 31% YoY, with margins improving to 21.7%, driven by operating leverage and disciplined cost management.” All this is for information. this is not a buy/sell recommendation. Thank you, Technofunda24